Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Shepard

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Anticancer Research|April 12, 2012
Effective targeting of the tumor microenvironment for cancer therapyPing Jiang, Xiaoming Li, Curtis B Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic CancerClifford J Whatcott, Caroline H Diep, Ping Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2014
Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammationZhongdong Huang, Chunmei Zhao, Yanling Chen, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.
Molecular Cancer Therapeutics|October 28, 2010
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal modelsCurtis B Thompson, H Michael Shepard, Patrick M O'Connor, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Oncotarget|November 26, 2019
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44Chunmei Zhao, Benjamin J Thompson, Kelly Chen, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Biomed Research International|August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironmentAnne Kultti, Chunmei Zhao, Netai C Singha, et al.
Pest Management Science|April 8, 2022
Ectopic expression of a rice triketone dioxygenase gene confers mesotrione tolerance in soybeanShunhong Dai, Nikolaos Georgelis, Mohamed Bedair, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Anticancer Research|April 12, 2012
Effective targeting of the tumor microenvironment for cancer therapyPing Jiang, Xiaoming Li, Curtis B Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic CancerClifford J Whatcott, Caroline H Diep, Ping Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2014
Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammationZhongdong Huang, Chunmei Zhao, Yanling Chen, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.
Molecular Cancer Therapeutics|October 28, 2010
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal modelsCurtis B Thompson, H Michael Shepard, Patrick M O'Connor, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Oncotarget|November 26, 2019
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44Chunmei Zhao, Benjamin J Thompson, Kelly Chen, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Biomed Research International|August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironmentAnne Kultti, Chunmei Zhao, Netai C Singha, et al.
Pest Management Science|April 8, 2022
Ectopic expression of a rice triketone dioxygenase gene confers mesotrione tolerance in soybeanShunhong Dai, Nikolaos Georgelis, Mohamed Bedair, et al.
Pageof 4